Rosen Law Firm Announces Key Deadline in GitLab Securities Class Action – Investors Urged to Act

New York – Investors who have acquired securities from GitLab Inc. are being reminded by the Rosen Law Firm, a global investor rights firm, of an upcoming November 4, 2024 deadline to apply as lead plaintiff in a major class-action lawsuit. This period concerns those who purchased GitLab’s securities between June 6, 2023, and March 4, 2024. Eligible investors might be entitled to compensation facilitated through a contingency fee arrangement requiring no direct out-of-pocket expenses. This lawsuit stems from accusations against GitLab Inc., claiming that executives made false and misleading statements about the company’s ability … Read more

SoLo Funds Hit with Class Action Lawsuit Over Alleged Hidden Loan Fees Despite Zero-Interest Claims

SoLo Funds, a popular financial platform known for its peer-to-peer lending services, has come under legal scrutiny again as it faces a new class action lawsuit alleging deceptive practices in its loan fees structure. The lawsuit, freshly filed, claims that while SoLo advertises its loans as having zero interest fees, it subtly pushes borrowers towards opting for additional “tip fees” and “donation fees” to secure loans. These additional costs, according to the complainants, effectively make the loans more expensive than the consumers initially anticipate. The legal challenge adds to the company’s growing list of legal … Read more

Exploring the Surge in PFAS Litigation: Duane Morris Webinar Unpacks Strategies and Trends in Class Action Battles

Philadelphia, PA — This week, the legal landscape grapples with escalating class action challenges, particularly those involving “forever chemicals,” substances that persist in the environment and are notoriously difficult to eliminate. Leading authorities from the law firm Duane Morris, in their latest webinar series, dissected recent developments in class action litigation tied to product liability cases involving these durable chemicals. The latest installment of the Duane Morris webinar series focused on the strategies for mitigating risks associated with per- and polyfluoroalkyl substances (PFAS), chemicals that are ubiquitous in various industries but are increasingly the subject … Read more

Federal Judge Halts National Elmiron Class Action; Multidistrict Litigation to Continue

A federal judge has recently decided against allowing a national class action lawsuit for individuals claiming harm from the drug Elmiron, though the legal challenges will continue under multidistrict litigation (MDL). This decision reflects the complex landscape of mass litigation cases where thousands seek justice for alleged wrongs committed by corporations or manufacturers. Elmiron, a prescription drug used for treating bladder pain, has been at the center of legal scrutiny after patients reported experiencing vision problems allegedly linked to the medication. The lawsuits demand accountability from the manufacturers, claiming that the risks were not properly … Read more